New Delhi: The GLP-1 based weight loss drugs are prescription medications used to treat type 2 diabetes and obesity but carry ...
India warns of GLP-1 drug risks as Ozempic and Wegovy prices fall, urging prescription-only use and tightening checks on ...
To prevent unauthorised sale, unsupervised use, and other malpractices, the Drug Controller of India has intensified its ...
12don MSN
'Clinical oversight can lead to…': Govt lists side-effects that can occur from weight-loss drugs
In India, only endocrinologists, internal medicine specialists, and cardiologists can prescribe GLP-1 weight loss drugs.
In Amylin Pharmaceuticals LLC & Anr. vs Assistant Controller of Patents (C.A.(COMM.IPD-PAT) 76/2022), the Delhi High Court upheld the refusal of a patent application for a sustained-release exenatide ...
Researchers from Thomas Jefferson University have discovered that combining two diabetes drugs—dapagliflozin and exenatide—can keep blood sugar levels under control for people with type 2 diabetes, ...
Osaka, Japan – Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan report a way for the body to make its own weight-loss drugs, ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers. A large-scale clinical trial found ...
ITCA650 is a unique formulation of exenatide currently in development, which delivers medication through an implantable subcutaneous pump delivery system. The osmotic mini pump provides a slow and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results